Wout Dekker joined the Supervisory Board of Hendrix Genetics on May 1, 2022. After leaving his position as CEO at Nutreco, he served on several supervisory boards in the for-profit and not-for-profit sector, including Rabobank, FrieslandCampina and the Princes Maxima Children's Oncology Center. Currently, Wout Dekker is a member of the supervisory board of SHV Holdings NV, Pon Holdings NV and Randstad NV.
Current role
Supervisory Board Member at Switzerland Global Enterprise
Supervisory Board Member at Switzerland Global Enterprise
Supervisory Board Member at Sirius Medical
Supervisory Board Member at Sirius Medical
Supervisory Board Member at Uzin Utz